Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

Bond Avillion 2 Development LP · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
psoriasis
psoriasis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810313
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.